The Japanese government said Tuesday it will cease subsidizing medical expenses for people infected with COVID-19, including no longer fixing the cost of medicines, at the end of March due to a fall in the number of cases. With Japan’s health care arrangements returning to pre-pandemic status from April, patients will have to pay 10 to 30 percent of the cost of coronavirus treatment drugs. Income levels and age determine how much each person pays. Government subsidies for hospitalizations and for medical institutions to reserve beds for coronavirus inpatients will also end. “Hospitals are maki…